By: IPP Bureau
Last updated : May 11, 2026 7:40 am
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
Sebia, in collaboration with the Diagnostic Division of Consortium of Accredited Healthcare Organizations (CAHO), has launched the Autoimmunity Masterclass Series, a six-part academic webinar initiative focused on improving the understanding, early diagnosis, and clinical management of autoimmune diseases.
The initiative comes at a time when autoimmune disorders are witnessing a noticeable rise, particularly in the post-COVID era, with many patients presenting complex and overlapping symptoms. According to a 2023 study published in the journal Clinical Rheumatology, patients recovering from COVID-19 showed a 40–45 percent higher risk of developing autoimmune diseases within the first year after infection.
Designed as a multidisciplinary learning platform, the webinar series will bring together clinicians, laboratory experts, and healthcare professionals to discuss evolving trends and challenges in autoimmune care.
The sessions will cover a broad spectrum of autoimmune conditions, including connective tissue diseases, Antiphospholipid Syndrome (APS), Systemic Lupus Erythematosus (SLE), gastrointestinal autoimmune disorders, celiac disease, rheumatoid arthritis, and related conditions. Each session will feature expert panels discussing disease presentation, diagnostic complexities, and emerging clinical practices.
The six webinars will be conducted throughout the year and aligned with relevant medical awareness themes to encourage wider participation and clinical relevance.
Nitin Wadhwa General Manager, Sebia India, said "This collaboration reflects our commitment to strengthening clinical and lab awareness in improving diagnostic pathways in autoimmunity. Through this structured masterclass series, we aim to bridge knowledge gaps and support clinicians in managing increasingly complex autoimmune cases more effectively."
Dr. Aparna Jairam, Chairperson, CAHO Diagnostic Division added: "Autoimmune diseases require a multidisciplinary approach for timely diagnosis and management. This series is a step towards creating a unified learning platform where experts can share insights and enhance patient care outcomes across the healthcare ecosystem."